Diabetes: Page 7

  • A phone-like device shows a bolus insulin measurement, with a white, U-shaped device to the right.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Insulet claims EOFlow copied patch-pump design in patent suit

    Insulet filed the lawsuit as competitor Medtronic plans to buy EOFlow for $738 million.

    By • Aug. 15, 2023
  • A cylindrical device on the left with a wifi signal, next to a black rounded device and a smartphone showing a blood glucose reading.
    Image attribution tooltip
    Permission granted by Senseonics
    Image attribution tooltip

    Senseonics seeks iCGM designation for implantable glucose monitor

    The company also plans to submit results of a pivotal trial for a version of its device that can be worn for a year.

    By • Aug. 11, 2023
  • An injection pen containing the drug semaglutide lies on a white plate.
    Image attribution tooltip
    Douglas Cliff via Getty Images
    Image attribution tooltip

    Device volumes to hold up against threat of Wegovy, other GLP-1 drugs: analysts

    Issues such as “nontrivial side effects, cost concerns and patient persistence” will mean physicians continue to use medical devices, analysts say.

    By • Aug. 9, 2023
  • The Dexcom G7 Continuous Glucose Monitoring (CGM) System
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom hails CGM share gains as driver of 25% revenue growth in Q2

    International market share gains and expanding coverage in the U.S. led the CGM maker to raise its revenue forecast for 2023.

    By • July 28, 2023
  • Professional photo of Felix Lee
    Image attribution tooltip
    Permission granted by Sanofi
    Image attribution tooltip
    Q&A

    Sanofi’s Felix Lee talks DarioHealth partnership, future of digital health

    The pharmaceutical company struck a strategic agreement with digital health company DarioHealth last year aimed at helping patients with diabetes manage their blood sugar levels. 

    By • July 21, 2023
  • Aveir leadless pacemaker by Abbott
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott Q2 net profit falls as weaker COVID test sales drag on revenue

    Stronger medical device sales and a recovery in the infant formula business partly offset the impact of reduced COVID-19 testing.

    By • July 20, 2023
  • A smartphone on the left shows time in range, and a small, square device on the right is compared to a quarter in size.
    Image attribution tooltip
    Courtesy of Tandem
    Image attribution tooltip

    Tandem’s Mobi insulin pump could reaccelerate growth next year: analyst

    The device, which is smaller than Tandem’s past pumps, could drive more people to switch from insulin injections, an analyst with Craig-Hallum said.

    By • July 12, 2023
  • From left to right: a white cylindrical device with a cord, a smartphone app showing blood glucose levels, a square device showing a blood glucose reading, and a white circular device.
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic secures Medicare coverage for MiniMed 780G insulin pump

    Medtronic has begun processing orders and will start shipping devices over the next few weeks.

    By • July 10, 2023
  • Becton Dickinson logo
    Image attribution tooltip
    Permission granted by Becton Dickinson
    Image attribution tooltip

    BD to shed 60 jobs as COVID demand, diabetes spinoff affect manufacturing plant

    The cuts are the latest in a wave of workforce reductions by medtech companies including Abbott Laboratories, Cook Medical, Illumina and Thermo Fisher Scientific.

    By • July 7, 2023
  • The Dexcom G7 Continuous Glucose Monitoring (CGM) System
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip
    Q&A

    Q&A: Dexcom’s Lawver shares strategy behind CGM for non-insulin users

    The continuous glucose monitor in development for people with Type 2 diabetes who don’t take insulin could expand the CGM market to 25 million more people in the U.S., the company’s new chief commercial officer said.

    By • June 30, 2023
  • Boxes of the diabetes drug Ozempic are seen on a pharmacy counter.
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    Diabetes remains fastest-growing medtech market despite some risk from new drugs: analysts

    The medicines could apply “short-lived pressures” to medtech companies by affecting the use of insulin, Mizuho analysts say. 

    By • June 30, 2023
  • A close-up shot of a woman's hands, handling a syringe of insulin.
    Image attribution tooltip
    ClarkandCompany via Getty Images
    Image attribution tooltip

    More than 1 billion people could have diabetes by 2050, study says

    A pair of studies published in the Lancet show that spending on diabetes care is expected to rise, but more work is needed to address structural inequities that affect access to treatment.

    By • June 26, 2023
  • From left to right: a white cylindrical device with a cord, a smartphone app showing blood glucose levels, a square device showing a blood glucose reading, and a white circular device.
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic links 780G insulin pump to benefits in kids as it works to grow sales

    A clinical trial found adolescent users of the pump can achieve improved blood glucose control without precisely counting carbohydrates.

    By • June 26, 2023
  • The Dexcom G7 Continuous Glucose Monitoring (CGM) System
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom targets 25M Americans with new CGM aimed at non-insulin-using diabetics

    The device will last for 15 days, include a cash-pay option and come with software designed for the needs of people who are yet to require insulin.

    By • June 26, 2023
  • Bigfoot insulin pen with smart cap and a hand
    Image attribution tooltip
    Courtesy of Bigfoot Medical
    Image attribution tooltip

    Bigfoot links smart insulin pen cap to improved glycemic control in real-world study

    Using the system can bring “rapid and durable improvement” in glycemic control for older adults with Type 2 diabetes who use multiple daily injections, researchers found.

    By • June 22, 2023
  • A person holds a yellow, pen-shaped device with a clear lid.
    Image attribution tooltip
    Joe Raedle via Getty Images
    Image attribution tooltip

    Novo Nordisk says in talks to acquire French device-maker Biocorp for $165M

    The offer per share is about 20% more than Biocorp’s closing stock price on June 2. The two companies plan to focus on drug delivery solutions for chronic diseases, such as diabetes.

    By • Updated June 6, 2023
  • Professional photo of Geoff Martha
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic posts profit, sales growth in Q4, agrees to buy Korean diabetes patch maker

    The company is “confident in delivering durable revenue growth in the year ahead” amid continued improvements in procedure volumes.

    By Peter Green • May 25, 2023
  • Image attribution tooltip
    Medtronic
    Image attribution tooltip

    Medtronic agrees to buy Korean insulin patch pump maker for $738m to boost diabetes business

    The tubeless, disposable insulin patch made by EOFlow will be integrated into Medtronic’s MiniMed 780G system.

    By • May 25, 2023
  • A man gives himself an insulin shot at home.
    Image attribution tooltip
    Boris Jovanovic via Getty Images
    Image attribution tooltip

    Beta Bionics wins FDA nod to challenge Medtronic for automated insulin pump market

    Beta Bionics’ device, aimed at people with Type 1 diabetes, has eliminated most of the data entry required by competitors.

    By • May 22, 2023
  • A woman lifting her shirt to expose her midriff and show a Verily Onduo CGM
    Image attribution tooltip
    Courtesy of Verily
    Image attribution tooltip

    Diabetes app developers must generate more data on clinical effectiveness, study says

    The researchers saw a need for more data on the wider clinical effectiveness of apps in the management of Type 1 diabetes and prediabetes.

    By • May 16, 2023
  • Professional photo of Dev Kurdikar
    Image attribution tooltip
    Permission granted by Embecta
    Image attribution tooltip

    Embecta joins Tidepool to develop insulin pump, raises Q2 growth outlook

    Embecta advanced its pump project by partnering with Tidepool, a nonprofit that has developed diabetes management software that can work across different brands of pumps and monitors.

    By • May 15, 2023
  • A person sits in front of a plate of food, holding a smartphone. They're wearing a patch on their left arm.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Insulet raises revenue forecast as Omnipod 5 drives US growth

    Insulet is confident it can grow the market for tubeless insulin pumps in the long term, an outlook the company bases on its device’s convenience.

    By • May 5, 2023
  • Tandem Diabetes Control-IQ
    Image attribution tooltip
    Courtesy of Tandem Diabetes
    Image attribution tooltip

    Tandem expects to meet ‘key’ goals even as rival’s device launch may curb short-term sales growth

    Tandem claims it has a better insulin pump than Medtronic’s recently approved rival MiniMed 780G device.

    By • May 4, 2023
  • The Dexcom G7 Continuous Glucose Monitoring (CGM) System
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom proposes $1.1B debt offering to add to existing $2.6B cash reserve

    About $189 million of the funds will go toward the repurchase of Dexcom stock and a portion will support other financial transactions, the company said.

    By • May 3, 2023
  • A person stands outside wearing a small, square device with a cord on their belt.
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic’s US diabetes business is floundering. Can the MiniMed 780G rescue it?

    The company, sidelined by a warning letter while competitors brought new products to market, is counting on its newest diabetes devices to spur “pent up interest.”

    By • May 2, 2023